Print

Catalent Pharma Solutions Announces Global Alliance With PAREXEL International (PRXL) to Streamline Clinical Trial Material Supply Chain Process  
10/2/2012 10:15:44 AM

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent Pharma Solutions, a world industry leader in drug development and advanced delivery technologies, today announced the establishment of a global alliance with PAREXEL International Corporation to help streamline the clinical trial supply process. The result of years of collaboration, the alliance will provide a seamless, fully integrated service offering to ensure the timely and efficient delivery of clinical trial materials.
//-->